Immuron
(NASDAQ) IMRN
Immuron Financials at a Glance
Market Cap
$5.74M
Revenue (TTM)
$13.04M
Net Income (TTM)
$8.50M
EPS (TTM)
$-0.48
P/E Ratio
-1.46
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$0.75
Volume
0
Open
$0.74
Price
$0.75
Volume
0
Open
$0.74
Previous Close
$0.75
Daily Range
$0.73 - $0.75
52-Week Range
$0.68 - $2.39
Dividend
$0.00
Beta (Volatility)
0.68 (Low)
Price
$0.75
Volume
0
Open
$0.74
Previous Close
$0.75
Daily Range
$0.73 - $0.75
52-Week Range
$0.68 - $2.39
IMRN News
IMRN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Immuron
Industry
Biotechnology
Sector
Health CareCEO
Steven Lydeamore, MBA
Website
www.immuron.comHeadquarters
Carlton, VIC 3130, AU
IMRN Financials
Key Financial Metrics (TTM)
Gross Margin
64%
Operating Margin
-68%
Net Income Margin
-62%
Return on Equity
-40%
Return on Capital
-38%
Return on Assets
-31%
Earnings Yield
-68.49%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.74M
Shares Outstanding
8.17M
Volume
0
Short Interest
0.00%
Avg. Volume
44.27K
Financials (TTM)
Gross Profit
$4.77M
Operating Income
$5.34M
EBITDA
$5.31M
Operating Cash Flow
$6.14M
Capital Expenditure
$0.00
Free Cash Flow
$6.14M
Cash & ST Invst.
$5.87M
Total Debt
$117.13K
Immuron Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$4.11M
+105.7%
Gross Profit
$2.60M
+96.1%
Gross Margin
63.42%
N/A
Market Cap
$5.74M
N/A
Market Cap/Employee
$820.13K
N/A
Employees
7
N/A
Net Income
$1.88M
-51.4%
EBITDA
$2.30M
-81.2%
Quarterly Fundamentals
Net Cash
$9.99M
+31.4%
Accounts Receivable
$2.52M
+119.6%
Inventory
$2.24M
+47.6%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-30.69%
N/A
Return on Invested Capital
-38.50%
N/A
Free Cash Flow
$2.43M
-21.9%
Operating Cash Flow
$2.43M
-21.7%